Crescent Grove Advisors, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
Crescent Grove Advisors, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$21,600
+10.8%
60,000
+172.7%
0.00%
+50.0%
Q4 2022$19,492
-40.9%
22,000
+4.8%
0.00%
-50.0%
Q3 2022$33,000
-17.5%
21,000
+5.0%
0.00%0.0%
Q2 2022$40,000
-14.9%
20,0000.0%0.00%
-20.0%
Q1 2022$47,000
-76.5%
20,000
-53.5%
0.01%
-73.7%
Q4 2021$200,000
+19.0%
43,000
+95.5%
0.02%
+5.6%
Q3 2021$168,000
-13.4%
22,000
+10.0%
0.02%
-10.0%
Q2 2021$194,00020,0000.02%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders